MSB:ASX
Mesoblast Ltd
A$1.93
arrow_downward
-1.28%(-0.025) 1D
Nov 13, 4:10:12 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MSB...
Open
A$1.96
High
A$2.00
Low
A$1.93
Mkt. cap
2.51B
Avg. vol.
3.92M
Volume
2.54M
52-wk high
A$3.31
52-wk low
A$1.74
EPS
-A$0.06
Shares outstanding
1.30B
No. of employees
108
Open
A$1.96
High
A$2.00
Low
A$1.93
Mkt. cap
2.51B
Avg. vol.
3.92M
Volume
2.54M
52-wk high
A$3.31
52-wk low
A$1.74
EPS
-A$0.06
Shares outstanding
1.30B
No. of employees
108
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Mesoblast Posts $115 Million in Revenue, Sets Sights on 2027 Back Pain Trial Readout
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd
CEOSilviu Itescu
Employees108
Founded2004
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitemesoblast.com